Effect of different Omega-3 supplementations
Phase 2
Completed
- Registration Number
- CTRI/2020/02/023143
- Lead Sponsor
- Arjuna Natural Private Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 80
Inclusion Criteria
Healthy male and female subjects aged 18-65 years
Willing to participate in the study and sign the informed consent form
Exclusion Criteria
Subject allergic to egg, fish oil or omega-3 supplements.
Subject consuming omega-3 supplements or having used Omega 3 supplements in 6 months preceding the intervention period.
Subjects with uncontrolled hypertension (SBP >=160 mm Hg or DBP >=100 mmHg), coronary artery disease, uncontrolled diabetes, renal impairment, cerebrovascular and peripheral artery disease which under the opinion of the investigator would influence the conduct or outcome of the study.
Subjects with history of alcohol abuse, other sedatives or drugs.
Subjects participated in another clinical study in the past 3 months
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in Omega -3 fatty acid level in blood plasma at Day 15 and Day 30 compared to baselineTimepoint: Baseline, Day 15, Day 30
- Secondary Outcome Measures
Name Time Method Change in Lipid profile, Serum calcium, Urine calcium at Day 15 and Day 30 compared to baseline <br/ ><br>Timepoint: Baseline, Day 15, Day 30